Results 231 to 240 of about 101,286 (277)

Effectiveness and Mechanism of Cryoablation in the Treatment of Oral Mucosal Melanoma

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Objectives To assess the effectiveness and safety of cryoablation for oral mucosal melanoma (OMM) and explore its underlying mechanisms to provide insights for precision treatment of OMM. Materials and Methods Patients diagnosed with OMM were divided into a cryoablation group and a noncryoablation therapy group.
Zhu You, Tianqi Zhang, Li Dai, Jie Wen, Mingyang Liu, Tengda Zhao, Guozhu Yin, Yihua Wu, Shizhou Zhang   +8 more
wiley   +1 more source

Adverse Renal Outcomes in Patients With Mesothelioma—A Territory‐Wide Real‐World Data

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Introduction Advances in mesothelioma management have translated into longer patient survival and different treatment‐related side effects including nephrotoxicity. The risk of developing adverse renal outcomes in patients with mesothelioma and associated risk factors remains undefined.
Wang Chun Kwok, James Chung Man Ho, Isaac Sze Him Leung, Desmond Yat Hin Yap   +3 more
wiley   +1 more source

Nanoparticle Albumin-Bound Paclitaxel and Nivolumab for PD-1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma. [PDF]

Cancer Med
Adkins D, Ley JC, Auberle C, Knapp B, Zaretsky J, Liu J, Oppelt P.   +6 more
europepmc   +1 more source

Phase II trial on nivolumab plus hypofractionated radiotherapy in patients with metastatic mucosal melanoma: PORTER-M3 trial. [PDF]

Immunooncol Technol
Nomura M, Yoshimura M, Yokota T, Boku S, Oze I, Ishikawa H, Muto M.   +6 more
europepmc   +1 more source

ANCA-negative pauci-immune crescentic glomerulonephritis associated with nivolumab in lung cancer. [PDF]

CEN Case Rep
Furuyama R, Eriguchi M, Kamikawa M, Beppu Y, Tamaki H, Uemura T, Tasaki H, Nishimoto M, Kosugi T, Tanabe K, Matsui M, Samejima KI, Tsuruya K.   +12 more
europepmc   +1 more source

Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab. [PDF]

Radiol Oncol
Ozkan E, Koksal M, Ece B, Koyun M, Kuzu OF, Acikgoz Y, Algin E.   +6 more
europepmc   +1 more source

Primary Malignant Melanoma of the Lung With a Long-Term Course: A Case Report. [PDF]

Respirol Case Rep
Fukushima Y, Azuma M, Miyagi Y, Kitamura M, Miyamoto K, Mizuki Y, Nakayama S, Ueda T.   +7 more
europepmc   +1 more source

Chihara D, Steiner RE, Nair R, et al. Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas. Blood Adv. 2025;9(7):1485-1491. [PDF]

Blood Adv
europepmc   +1 more source